Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Holler

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Dec 02, 2021 12:47pm

161 Views

Post# 34190749

RE:RE:RE:Holler

If it's a licensing deal they are close to signing things are about to ramp up and Frank will be needed as Sernova goes through some major growth. Be like the good old days at Angiotech. I will agree not much until next year. Feels that way pretty much across the board.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China